7-116741100-T-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_000245.4(MET):​c.1701+75T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00597 in 1,545,022 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).

Frequency

Genomes: 𝑓 0.0039 ( 4 hom., cov: 31)
Exomes 𝑓: 0.0062 ( 36 hom. )

Consequence

MET
NM_000245.4 intron

Scores

2

Clinical Significance

not provided no classification provided O:1

Conservation

PhyloP100: 0.0670

Publications

0 publications found
Variant links:
Genes affected
MET (HGNC:7029): (MET proto-oncogene, receptor tyrosine kinase) This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016]
MET Gene-Disease associations (from GenCC):
  • hereditary papillary renal cell carcinoma
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • papillary renal cell carcinoma
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen
  • autosomal recessive nonsyndromic hearing loss 97
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • osteofibrous dysplasia
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • arthrogryposis, distal, IIa 11
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00386 (583/150894) while in subpopulation NFE AF = 0.00669 (453/67672). AF 95% confidence interval is 0.00618. There are 4 homozygotes in GnomAd4. There are 261 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 4 AD,AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000245.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MET
NM_000245.4
MANE Select
c.1701+75T>G
intron
N/ANP_000236.2
MET
NM_001127500.3
c.1701+75T>G
intron
N/ANP_001120972.1
MET
NM_001324402.2
c.411+75T>G
intron
N/ANP_001311331.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MET
ENST00000397752.8
TSL:1 MANE Select
c.1701+75T>G
intron
N/AENSP00000380860.3
MET
ENST00000318493.11
TSL:1
c.1701+75T>G
intron
N/AENSP00000317272.6
MET
ENST00000436117.3
TSL:1
n.1701+75T>G
intron
N/AENSP00000410980.2

Frequencies

GnomAD3 genomes
AF:
0.00387
AC:
583
AN:
150780
Hom.:
4
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00137
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00172
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00202
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00669
Gnomad OTH
AF:
0.00242
GnomAD2 exomes
AF:
0.00430
AC:
847
AN:
197196
AF XY:
0.00443
show subpopulations
Gnomad AFR exome
AF:
0.00196
Gnomad AMR exome
AF:
0.000932
Gnomad ASJ exome
AF:
0.00355
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00173
Gnomad NFE exome
AF:
0.00801
Gnomad OTH exome
AF:
0.00633
GnomAD4 exome
AF:
0.00620
AC:
8644
AN:
1394128
Hom.:
36
Cov.:
24
AF XY:
0.00602
AC XY:
4180
AN XY:
693942
show subpopulations
African (AFR)
AF:
0.00126
AC:
39
AN:
30926
American (AMR)
AF:
0.00130
AC:
50
AN:
38432
Ashkenazi Jewish (ASJ)
AF:
0.00359
AC:
90
AN:
25098
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39124
South Asian (SAS)
AF:
0.000139
AC:
11
AN:
79070
European-Finnish (FIN)
AF:
0.00226
AC:
108
AN:
47784
Middle Eastern (MID)
AF:
0.00110
AC:
6
AN:
5476
European-Non Finnish (NFE)
AF:
0.00757
AC:
8101
AN:
1070368
Other (OTH)
AF:
0.00413
AC:
239
AN:
57850
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
410
821
1231
1642
2052
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
308
616
924
1232
1540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00386
AC:
583
AN:
150894
Hom.:
4
Cov.:
31
AF XY:
0.00354
AC XY:
261
AN XY:
73696
show subpopulations
African (AFR)
AF:
0.00136
AC:
56
AN:
41026
American (AMR)
AF:
0.00172
AC:
26
AN:
15144
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5140
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4750
European-Finnish (FIN)
AF:
0.00202
AC:
21
AN:
10412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00669
AC:
453
AN:
67672
Other (OTH)
AF:
0.00239
AC:
5
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
29
57
86
114
143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00558
Hom.:
1
Bravo
AF:
0.00392

ClinVar

Significance: not provided
Submissions summary: Other:1
Revision: no classification provided
LINK: link

Submissions by phenotype

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.66
DANN
Benign
0.44
PhyloP100
0.067
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs553431706; hg19: chr7-116381154; COSMIC: COSV59258063; API